Skip to main content

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the U.S. planning to build their families, highlights the unique challenges LGBTQ+ patients face, including struggles with insufficient access to care, financial constraints, and lack of mental health support throughout their family building journey.

Progyny’s survey underscores the pivotal role employers can play in providing inclusive and comprehensive family building benefits that support all paths to parenthood. The findings highlight that employers can significantly improve the lives of LGBTQ+ employees by providing extensive support and resources for family building – these benefits are proven to promote a more inclusive workplace and strengthen employee loyalty. This data equips benefit decision makers with the insights needed to effectively support LGBTQ+ employees throughout their fertility and family building journeys.

“At Progyny, we believe that everyone deserves the opportunity to build their family, regardless of their background or identity,” said Pete Anevski, CEO of Progyny. “For the LGBTQ+ community, this often means navigating additional hurdles and challenges. By adopting comprehensive and inclusive family building benefits, employers can help ensure that every individual has access to the care and resources they need to realize their dream of becoming a parent.”

Key findings
Of the LGBTQ+ individuals surveyed:

  • The majority of respondents (76%) indicated they are concerned about the cost of family building.
  • Over half (54%) of respondents said that the costs associated with family building prevented them from growing their family.
  • An overwhelming amount (83%) of respondents said they would consider leaving their employer for one that offered family building benefits.
  • A significant 85% of respondents indicated they would take on a second job to gain employer-sponsored family building care.
  • Nearly half of respondents (48%) said they are exploring adoption and a third (29%) said they are considering surrogacy.

“Inclusive family building benefits are transformative for employees on their journey to parenthood, especially those in the LGBTQ+ community,” said Cynthia McEwen, Head of DE&I at Progyny. “These benefits not only provide crucial support and resources but also send a powerful message of acceptance and validation. When employers offer comprehensive family building benefits, they foster a sense of belonging, company allegiance, and demonstrate their understanding of the importance of equity, inclusion, and access.”

Progyny partners with over 460 leading employers to deliver personalized and impactful fertility and family building benefits. Progyny’s equitable benefit design ensures access to enrollees of all genders, sexual orientations, and relationship statuses, and provides access to comprehensive coverage for services including preconception, IUI, IVF, fertility preservation, postpartum, adoption, and surrogacy. Each patient also has convenient access to over 1,000 of the nation’s most sought-after fertility specialists so they can choose a physician who best meets their needs, as well as concierge support from a dedicated fertility coach to ease the stress and anxiety common to fertility treatment and family building journeys.

For more information about Progyny’s LGBTQ+ Family Building Survey, visit progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.  

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women’s health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Alexis Ford
media@progyny.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.